I was a patient in FDA/MAPS MDMA trials treating PTSD, I experienced deep healing, but the curated music playlists often felt distracting, disruptive, and even frightening at times. I soon found out that this wasn't a rare experience or opinion. 

​

My time in the U.S. Army taught me to question the status quo, “If not, Why not?”: if these playlists are falling short, why not build something better? So I paused my 30‑year career as a music producer, drew on what I’d learned earning a degree in Music and Electro‑Acoustics, and focused intensely on all I’d learned in over a decade of therapy and 35 years of living with PTSD. The challenge was set, and the first steps began with humpback whales and US Navy submarines.

​

I set out to craft a sound solution that enables patients to stay fully immersed in their healing, to focus 100% of their energy on their therapy, and frees clinicians to do the same for their patients. Therapists and patients in the same FDA trial used the early PsySonics for MDMA successfully and confirmed that this is a better solution.

PsySonics was born.​

​

Rogers Masson

Founder/CEO